Haemophilus parasuis (Glaesser's Disease) in Pigs: Polyserositis, Meningitis, and Diagnosis
Etiology and Taxonomic Classification
Haemophilus parasuis is a Gram-negative, pleomorphic, non-motile, non-spore-forming coccobacillus belonging to the family Pasteurellaceae. The organism is a NAD-dependent (V-factor) bacterium, requiring nicotinamide adenine dinucleotide for in vitro growth, but it does not require hemin (X-factor). This biochemical distinction separates H. parasuis from Haemophilus suis, a now-obsolete taxon. The species is strictly adapted to swine and is considered part of the normal upper respiratory tract microbiota of pigs. However, virulent strains can invade systemic sites and cause Glaesser's disease, a condition historically termed Glasser's disease after the pathologist who first described the fibrinous polyserositis syndrome in swine.
The bacterium is classified into 15 serovars (serovars 1 through 15) based on heat-stable antigenic determinants, with additional non-typable isolates frequently recovered from clinical and carrier animals. Serovar 4 and serovar 5 are among the most commonly associated with clinical disease in many swine-producing regions. Serovar 1, 2, 5, 10, 12, 13, and 14 are generally considered highly virulent, whereas serovars 3, 6, 7, 8, 9, and 11 are often associated with mild or subclinical respiratory tract colonization. The correlation between serovar and virulence is not absolute and is influenced by host immune status, concurrent infections, and environmental stressors.
Epidemiology and Transmission
Haemophilus parasuis is an obligate swine pathogen with no known reservoir in other animal species. Transmission occurs primarily via direct contact with respiratory secretions from colonized or diseased pigs. Aerosol transmission over short distances is possible, particularly in high-density confinement operations. The bacterium can survive for limited periods in the environment, typically less than 24 hours on fomites, but survival is prolonged in moist organic material at cool temperatures.
The epidemiology of Glaesser's disease is closely tied to management practices. Disease outbreaks are most common in nursery and early grower pigs, typically between 3 and 10 weeks of age, coinciding with the waning of maternally derived antibodies and the stress of weaning, mixing, and transport. High health-status herds, including specific-pathogen-free (SPF) and medicated-early-weaning (MEW) operations, are particularly vulnerable because their pigs lack prior exposure and adaptive immunity. Introduction of carrier animals into naive herds can precipitate explosive outbreaks with high morbidity and mortality.
Co-infection with other respiratory pathogens, including porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza virus, and Mycoplasma hyopneumoniae, potentiates the severity of H. parasuis disease. These viral and bacterial agents compromise mucociliary clearance and alveolar macrophage function, facilitating systemic invasion by H. parasuis.
Pathogenesis and Virulence Factors
The pathogenesis of H. parasuis involves initial colonization of the upper respiratory tract, followed by invasion of the bloodstream and dissemination to serosal surfaces, meninges, and joints. The bacterium expresses several virulence determinants that facilitate adhesion, immune evasion, and tissue damage.
Key virulence factors include:
- Polysaccharide capsule: The capsule is a major antiphagocytic factor. Encapsulated strains resist complement-mediated opsonization and phagocytosis by alveolar macrophages and neutrophils. Non-encapsulated strains are rapidly cleared from the bloodstream.
- Lipooligosaccharide (LOS): The LOS of H. parasuis is a potent endotoxin that triggers the release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1). LOS contributes to the development of fibrinous exudates on serosal surfaces and the breakdown of the blood-brain barrier.
- Outer membrane proteins (OMPs): Several OMPs, including OmpA and OmpP2, mediate adherence to porcine respiratory epithelial cells and extracellular matrix components. OMPs also elicit a host antibody response, though their role in protective immunity is variable across serovars.
- Transferrin-binding proteins (TbpA and TbpB): These proteins allow H. parasuis to acquire iron from porcine transferrin, an essential nutrient for bacterial growth in the host.
- Neuraminidase (sialidase): This enzyme cleaves sialic acid residues from host glycoproteins, potentially exposing receptors for bacterial adhesion and modulating host immune recognition.
Systemic invasion occurs when virulent strains breach the respiratory epithelial barrier, often facilitated by concurrent viral infection or physical damage to the mucosa. Once in the bloodstream, the bacterium multiplies rapidly and disseminates to the pleura, pericardium, peritoneum, meninges, and synovial membranes. The host inflammatory response, driven by LOS and cytokine release, results in the deposition of fibrin-rich exudates, leading to the hallmark lesions of polyserositis and meningitis.
Clinical Signs
The clinical presentation of Glaesser's disease varies with the age and immune status of the pig, the virulence of the infecting strain, and the presence of concurrent infections. Two main clinical forms are recognized: the acute systemic form and the subacute or chronic form.
Acute Systemic Form
The acute form typically occurs in naive pigs 3 to 10 weeks of age. Clinical signs develop rapidly, often within 24 to 48 hours of exposure. Affected pigs present with:
- High fever (40.5 to 42.0 degrees Celsius)
- Anorexia and depression
- Dyspnea or tachypnea, often with an abdominal breathing pattern
- Cyanosis of the extremities, including the ears, snout, and tail
- Reluctance to move or recumbency due to polyserositis and arthritis
- Neurologic signs, including ataxia, nystagmus, paddling, opisthotonos, and convulsions, indicative of meningitis
- Sudden death in peracute cases, often without premonitory signs
Morbidity in naive herds can reach 50 to 75 percent, and mortality in untreated cases may approach 50 percent or higher.
Subacute and Chronic Form
In herds with partial immunity or in older pigs, the disease may present as a milder syndrome characterized by:
- Intermittent fever
- Mild to moderate lameness due to polyarthritis
- Coughing and nasal discharge
- Reduced growth rates and feed conversion efficiency
- Occasional cases of pericarditis or pleuritis detected at slaughter
Chronic infections may persist for weeks, with affected pigs serving as a source of continued environmental contamination.
Pathology
Gross pathological findings in acute Glaesser's disease are dominated by fibrinous polyserositis. The lesions are typically bilateral and symmetrical.
Polyserositis
Fibrinous exudates are observed on the pleural, pericardial, and peritoneal surfaces. The exudate may be thin and serofibrinous in early stages, progressing to thick, yellow-white fibrin deposits that coat the organs. In severe cases, the pericardium is distended with turbid, fibrin-rich fluid, and the heart is covered by a shaggy fibrin layer (so-called "bread-and-butter" pericarditis). The pleural cavity may contain similar exudates, and the lungs may be adherent to the chest wall. Peritoneal involvement results in fibrinous peritonitis, with fibrin strands adherent to the liver, spleen, and intestinal serosa.
Meningitis
The meninges are congested and opaque, with a fibrinous or purulent exudate visible over the surface of the brain and spinal cord. The cerebrospinal fluid (CSF) is turbid and may contain elevated protein and leukocyte counts. Histologically, there is a suppurative leptomeningitis with neutrophil infiltration, fibrin deposition, and vascular thrombosis.
Arthritis
Synovial membranes are hyperemic and edematous, and the joint cavities contain increased volumes of turbid, fibrin-flecked synovial fluid. The carpal, tarsal, and stifle joints are most commonly affected.
Other Lesions
Pulmonary lesions are variable and may include cranioventral bronchopneumonia, often attributable to concurrent infections. Splenomegaly and lymphadenopathy are common. Petechial hemorrhages may be present on serosal surfaces and in the renal cortex.
Diagnosis
A definitive diagnosis of Glaesser's disease requires the isolation or molecular detection of H. parasuis from systemic sites in a pig with compatible clinical signs and lesions. The diagnostic approach integrates clinical assessment, gross pathology, histopathology, bacteriology, and molecular methods.
Clinical and Gross Pathologic Diagnosis
Presumptive diagnosis is based on the triad of fibrinous polyserositis, meningitis, and polyarthritis in young pigs. Differential diagnoses include other causes of polyserositis and meningitis in swine, such as:
- Streptococcus suis (meningitis, arthritis, and septicemia)
- Mycoplasma hyorhinis (polyserositis and arthritis, typically without meningitis)
- Actinobacillus suis (septicemia and polyserositis)
- Erysipelothrix rhusiopathiae (arthritis and vegetative endocarditis)
- Porcine circovirus type 2 (PCV2)-associated systemic disease (lymphoid depletion and granulomatous inflammation)
- Salmonella enterica serovar Choleraesuis (septicemia and enterocolitis)
The presence of fibrinous exudates on multiple serosal surfaces, particularly in the absence of significant pulmonary consolidation, strongly suggests H. parasuis infection.
Bacteriologic Culture
H. parasuis is a fastidious organism that requires NAD-supplemented media for growth. Chocolate agar or tryptic soy agar supplemented with 5 percent sheep blood and a nurse colony of Staphylococcus aureus (satellitism phenomenon) are standard isolation media. Alternatively, commercial NAD-supplemented media such as chocolate agar with IsoVitaleX can be used.
Samples for culture should be collected aseptically from systemic sites, including pleural fluid, pericardial fluid, peritoneal fluid, CSF, joint fluid, and brain tissue. Nasal swabs are not recommended for diagnostic confirmation because they may reflect only colonization.
Colonies appear as small, grayish, translucent, non-hemolytic colonies after 24 to 48 hours of incubation at 37 degrees Celsius in a 5 percent carbon dioxide atmosphere. The organism is oxidase-positive, catalase-positive, and urease-negative. Biochemical identification can be performed using commercial identification systems, though these may misidentify some isolates.
Molecular Diagnostics
Polymerase chain reaction (PCR) assays targeting the 16S rRNA gene or species-specific genes, such as infB (translation initiation factor IF-2), are highly sensitive and specific for the detection of H. parasuis. Real-time PCR (qPCR) allows quantification of bacterial load and is particularly useful for detecting the organism in CSF, joint fluid, and tissue homogenates.
PCR-based typing methods, including serovar-specific multiplex PCR and multilocus sequence typing (MLST), are used for epidemiologic surveillance and to distinguish virulent from avirulent strains. MLST targets seven housekeeping genes (infB, gnd, rpoB, mdh, 6pgd, frdB, and atpD) and provides a high-resolution view of population structure.
Serology
Serologic testing using an enzyme-linked immunosorbent assay (ELISA) can detect antibodies against H. parasuis, but its utility for individual diagnosis is limited due to the high prevalence of subclinical infection and the variability of antibody responses across serovars. Serology is more useful for herd-level surveillance and for assessing vaccine responses.
Diagnostic Decision Workflow
The following Mermaid diagram outlines a diagnostic decision tree for suspected Glaesser's disease.
flowchart TD
A[Clinical signs: fever, polyserositis, meningitis, arthritis in pigs 3-10 weeks], > B{Postmortem examination}
B, > C[Fibrinous polyserositis, meningitis, arthritis present]
C, > D[Collect samples: pleural fluid, pericardial fluid, CSF, joint fluid, brain]
D, > E{Diagnostic testing}
E, > F[Bacteriologic culture on NAD-supplemented media]
E, > G[PCR (16S rRNA or infB gene) on fluid or tissue]
F, > H[Colonies: small, gray, non-hemolytic; satellitism positive]
H, > I[Biochemical confirmation: oxidase+, catalase+, urease-]
G, > J[Positive PCR result from systemic site]
I, > K[Confirmatory PCR or serotyping]
J, > K
K, > L[Definitive diagnosis: Glaesser's disease]
B, > M[No fibrinous polyserositis or meningitis]
M, > N[Consider differentials: S. suis, M. hyorhinis, A. suis, E. rhusiopathiae]
Treatment
Antimicrobial therapy is most effective when initiated early in the course of disease. The choice of antimicrobial should be guided by in vitro susceptibility testing, as resistance patterns vary geographically and over time. H. parasuis is generally susceptible to beta-lactam antibiotics, cephalosporins, fluoroquinolones, tetracyclines, and potentiated sulfonamides. However, resistance to tetracyclines and macrolides has been reported in some regions.
Parenteral administration is preferred in acutely ill pigs because of anorexia and impaired gastrointestinal absorption. Ceftiofur, enrofloxacin, and amoxicillin are commonly used injectable agents. Water-soluble antibiotics, such as amoxicillin or trimethoprim-sulfadiazine, can be administered via drinking water for group treatment during outbreaks.
Supportive care, including provision of clean, dry bedding, adequate ventilation, and easy access to feed and water, is critical for recovery. Anti-inflammatory drugs, such as flunixin meglumine or meloxicam, may reduce fever and inflammation, improving survival in severely affected pigs.
Control and Prevention
Control of Glaesser's disease relies on a combination of management practices, biosecurity, and vaccination.
Management Practices
- All-in/all-out production systems reduce the carryover of H. parasuis between groups.
- Minimizing mixing of pigs from different sources reduces the introduction of new serovars.
- Reducing stocking density and improving ventilation decrease respiratory pathogen load.
- Early weaning and segregated early weaning (SEW) protocols can reduce vertical transmission from sows to piglets.
- Control of concurrent viral infections, particularly PRRSV and swine influenza, through vaccination and management reduces disease potentiation.
Vaccination
Commercial bacterin vaccines, typically containing inactivated whole cells of multiple serovars (most commonly serovars 1, 4, 5, and 12), are available in many regions. Autogenous vaccines prepared from farm-specific isolates are also used in herds with persistent problems. Vaccination of sows provides passive immunity to piglets via colostrum, protecting them during the critical nursery period. Piglet vaccination at 3 to 4 weeks of age, with a booster 2 to 3 weeks later, is also practiced.
The efficacy of bacterin vaccines is variable and serovar-dependent. Protection is primarily antibody-mediated, and cross-protection between serovars is limited. Novel vaccine approaches, including subunit vaccines based on OMPs or LOS-core antigens, are under investigation but are not yet commercially available.
Biosecurity
- Quarantine and acclimatization of incoming stock for at least 4 weeks reduces the risk of introducing new serovars.
- Strict visitor and equipment disinfection protocols prevent mechanical transmission.
- Rodent and insect control reduces the potential for indirect transmission, though the role of vectors in H. parasuis epidemiology is minor compared to direct contact.
Conclusion
Haemophilus parasuis remains a significant cause of morbidity and mortality in swine production systems worldwide. The clinical syndrome of Glaesser's disease, characterized by fibrinous polyserositis, meningitis, and arthritis, is a diagnostic hallmark. Accurate diagnosis requires a combination of clinical, pathological, and laboratory methods, with PCR providing rapid and sensitive detection. Control is achieved through integrated management, biosecurity, and vaccination, though the antigenic diversity of the organism presents ongoing challenges. Continued surveillance of serovar distribution and antimicrobial resistance patterns is essential for effective disease management.
References
- Oliveira S, Pijoan C. Haemophilus parasuis: new trends on diagnosis, epidemiology and control. Veterinary Microbiology. 2004;99(1):1-12.
- Brockmeier SL, Register KB, Kuehn JS, Nicholson TL, Loving CL, Bayles DO, et al. Virulence and draft genome sequences of Haemophilus parasuis isolates from different serovars. Infection and Immunity. 2014;82(5):2069-2079.
- Aragon V, Segales J, Oliveira S. Haemophilus parasuis: a review of virulence factors and pathogenesis. Veterinary Journal. 2012;192(2):147-154.
- Zhang B, Tang C, Liao M, Yue H. Update on the pathogenesis of Haemophilus parasuis infection. Veterinary Microbiology. 2014;168(2-4):241-248.
- Costa-Hurtado M, Aragon V. Advances in the quest for virulence factors of Haemophilus parasuis. Veterinary Journal. 2013;198(3):571-576.